Future research aims to better understand the complexity of proliferative signaling and develop more effective treatments:
Single-Cell Sequencing: This technology can provide insights into the heterogeneity of cancer cells and their signaling networks. Artificial Intelligence: AI can be used to analyze large datasets and predict the most effective drug combinations. Immunotherapy: Combining immunotherapy with targeted therapies could enhance anti-tumor responses.
In conclusion, sustaining proliferative signaling is a cornerstone of cancer biology. Understanding the mechanisms and pathways involved offers numerous opportunities for developing targeted therapies and improving patient outcomes.
